FDA Inspection 1192875 - Kelix bio (Malta) Ltd. - December 16, 2022

Record Details

This FDA Inspection record concerns Kelix bio (Malta) Ltd., with an inspection on December 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Kelix bio (Malta) Ltd.
Inspection Date: December 16, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 4f1c29ce-6b07-4fdb-8263-4efb10882a95

Violation Codes4

21 CFR 211.160(a)21 CFR 211.19221 CFR 211.42(c)(10)(v)21 CFR 211.63

Full citation text and observation details available on the Dashboard.